Search Results - "Bruns, C."

Working alone together: Coordination in collaboration across domains of expertise by Bruns, Hille C

“…This study develops theory on how coordination occurs in collaboration across multiple expert domains. Ethnographic fieldwork at two top U.S. universities…”
Get full text

Mortality after liver surgery in Germany by Filmann, N., Walter, D., Schadde, E., Bruns, C., Keck, T., Lang, H., Oldhafer, K., Schlitt, H. J., Schön, M. R., Herrmann, E., Bechstein, W. O., Schnitzbauer, A. A.

“…Background Mortality rates after liver surgery are not well documented in Germany. More than 1000 hospitals offer liver resection, but there is no central…”
Get full text

Adaptive introgression enables evolutionary rescue from extreme environmental pollution by Oziolor, Elias M, Reid, Noah M, Yair, Sivan, Lee, Kristin M, Guberman VerPloeg, Sarah, Bruns, Peter C, Shaw, Joseph R, Whitehead, Andrew, Matson, Cole W

“…Radical environmental change that provokes population decline can impose constraints on the sources of genetic variation that may enable evolutionary rescue…”
Get full text

Detection of sub-nmol amounts of the antiviral drug favipiravir in 19F MRI using photo-chemically induced dynamic nuclear polarization by Bernarding, J., Bruns, C., Prediger, I., Mützel, M., Plaumann, M.

“…In biological tissues, 19 F magnetic resonance (MR) enables the non-invasive, background-free detection of 19 F-containing biomarkers. However, the…”
Get full text

The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate by Gergely, P, Nuesslein‐Hildesheim, B, Guerini, D, Brinkmann, V, Traebert, M, Bruns, C, Pan, S, Gray, NS, Hinterding, K, Cooke, NG, Groenewegen, A, Vitaliti, A, Sing, T, Luttringer, O, Yang, J, Gardin, A, Wang, N, Crumb Jr, WJ, Saltzman, M, Rosenberg, M, Wallström, E

“…BACKGROUND AND PURPOSE BAF312 is a next‐generation sphingosine 1‐phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors. S1P1 receptors are…”
Get full text

Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer by Damanakis, A. I., Gebauer, F., Stapper, A., Schlößer, H. A., Ghadimi, M., Schmidt, T., Schiffmann, L. M., Fuchs, H., Zander, T., Quaas, A., Bruns, C. J., Schroeder, W.

“…Background Histopathologic regression following neoadjuvant treatment (NT) of oesophageal cancer is a prognostic factor of survival, but the nodal status is…”
Get full text

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial by Keck, Tobias, Wellner, U F, Bahra, M, Klein, F, Sick, O, Niedergethmann, M, Wilhelm, T J, Farkas, S A, Börner, T, Bruns, C, Kleespies, A, Kleeff, J, Mihaljevic, A L, Uhl, W, Chromik, A, Fendrich, V, Heeger, K, Padberg, W, Hecker, A, Neumann, U P, Junge, K, Kalff, J C, Glowka, T R, Werner, J, Knebel, P, Piso, P, Mayr, M, Izbicki, J, Vashist, Y, Bronsert, P, Bruckner, T, Limprecht, R, Diener, M K, Rossion, I, Wegener, I, Hopt, U T

“…OBJECTIVES:To assess pancreatic fistula rate and secondary endpoints after pancreatogastrostomy (PG) versus pancreatojejunostomy (PJ) for reconstruction in…”
Get full text

Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth by Schiffmann, L. M., Werthenbach, J. P., Heintges-Kleinhofer, F., Seeger, J. M., Fritsch, M., Günther, S. D., Willenborg, S., Brodesser, S., Lucas, C., Jüngst, C., Albert, M. C., Schorn, F., Witt, A., Moraes, C. T., Bruns, C. J., Pasparakis, M., Krönke, M., Eming, S. A., Coutelle, O., Kashkar, H.

“…The vasculature represents a highly plastic compartment, capable of switching from a quiescent to an active proliferative state during angiogenesis. Metabolic…”
Get full text

Interval between neoadjuvant chemoradiotherapy and surgery for locally advanced esophageal cancer-When to operate? by Schröder, W, Bruns, C J

Get more information

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3 by Modest, D.P., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C.J., Gebauer, B., Modest, H.I., Held, S., Folprecht, G., Heinemann, V., Neumann, U.P.

“…The FIRE-3 trial investigated combination chemotherapy plus either cetuximab or bevacizumab in patients with untreated metastatic colorectal cancer (mCRC) not…”
Get full text

Blumgart anastomosis for pancreaticojejunostomy minimizes severe complications after pancreatic head resection by Kleespies, A., Rentsch, M., Seeliger, H., Albertsmeier, M., Jauch, K.-W., Bruns, C. J.

“…Background: Leakage from the pancreaticojejunostomy is the major cause of septic complications after partial pancreaticoduodenectomy. This study evaluated a…”
Get full text

Two-current correlations in the pion on the lattice by Bali, Gunnar S., Bruns, Peter C., Castagnini, Luca, Diehl, Markus, Gaunt, Jonathan R., Gläßle, Benjamin, Schäfer, Andreas, Sternbeck, André, Zimmermann, Christian

“…A bstract We perform a systematic study of the correlation functions of two quark currents in a pion using lattice QCD. We obtain good signals for all but one…”
Get full text

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group by Seufferlein, T., Uhl, W., Kornmann, M., Algül, H., Friess, H., König, A., Ghadimi, M., Gallmeier, E., Bartsch, D.K., Lutz, M.P., Metzger, R., Wille, K., Gerdes, B., Schimanski, C.C., Graupe, F., Kunzmann, V., Klein, I., Geissler, M., Staib, L., Waldschmidt, D., Bruns, C., Wittel, U., Fichtner-Feigl, S., Daum, S., Hinke, A., Blome, L., Tannapfel, A., Kleger, A., Berger, A.W., Kestler, A.M.R., Schuhbaur, J.S., Perkhofer, L., Tempero, M., Reinacher-Schick, A.C., Ettrich, T.J.

“…Data on perioperative chemotherapy in resectable pancreatic ductal adenocarcinoma (rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy…”
Get full text

A Novel, Blocking, Fc‐Silent Anti‐CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion by Cordoba, F., Wieczorek, G., Audet, M., Roth, L., Schneider, M. A., Kunkler, A., Stuber, N., Erard, M., Ceci, M., Baumgartner, R., Apolloni, R., Cattini, A., Robert, G., Ristig, D., Munz, J., Haeberli, L., Grau, R., Sickert, D., Heusser, C., Espie, P., Bruns, C., Patel, D., Rush, J. S.

“…CD40–CD154 pathway blockade prolongs renal allograft survival in nonhuman primates (NHPs). However, antibodies targeting CD154 were associated with an…”
Get full text

Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis by Stolze, T., Franke, S., Haybaeck, J., Moehler, M., Grimminger, P. P., Lang, H., Roth, W., Gockel, I., Kreuser, N., Bläker, H., Wittekind, C., Lordick, F., Vieth, M., Veits, L., Waidmann, O., Lingohr, P., Peitz, U., Schildberg, C., Kruschewski, M., Vassos, N., Goni, E., Bruns, C. J., Ridwelski, K., Wolff, S., Lippert, H., Schumacher, J., Malfertheiner, P., Venerito, M.

“…Purpose In a post hoc analysis of the MAGIC trial, patients with curatively resected gastric cancer (GC) and mismatch repair (MMR) deficiency (MMRd) had better…”
Get full text

Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? by Abbott, D.H., Barnett, D.K., Bruns, C.M., Dumesic, D.A.

“…The aetiology of polycystic ovary syndrome (PCOS) remains unknown. This familial syndrome is prevalent among reproductive-aged women and its inheritance…”
Get full text

Two-stage hybrid Ivor-Lewis esophagectomy as surgical strategy to reduce postoperative morbidity for high-risk patients by Bartella, I., Brinkmann, S., Fuchs, H., Leers, J., Schlößer, H. A., Bruns, C. J., Schröder, W.

“…Background Ivor-Lewis esophagectomy (ILE) is the standard surgical care for esophageal cancer patients but postoperative morbidity impairs quality of life and…”
Get full text

TEsoNet: knowledge transfer in surgical phase recognition from laparoscopic sleeve gastrectomy to the laparoscopic part of Ivor–Lewis esophagectomy by Eckhoff, J. A., Ban, Y., Rosman, G., Müller, D. T., Hashimoto, D. A., Witkowski, E., Babic, B., Rus, D., Bruns, C., Fuchs, H. F., Meireles, O.

“…Background Surgical phase recognition using computer vision presents an essential requirement for artificial intelligence-assisted analysis of surgical…”
Get full text

The ρ-meson light-cone distribution amplitudes from lattice QCD by Braun, Vladimir M., Bruns, Peter C., Collins, Sara, Gracey, John A., Gruber, Michael, Göckeler, Meinulf, Hutzler, Fabian, Pérez-Rubio, Paula, Schäfer, Andreas, Söldner, Wolfgang, Sternbeck, André, Wein, Philipp

“…A bstract We present the results of a lattice study of the normalization constants and second moments of the light-cone distribution amplitudes of…”
Get full text

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial by Nilsson, K., Klevebro, F., Sunde, B., Rouvelas, I., Lindblad, M., Szabo, E., Halldestam, I., Smedh, U., Wallner, B., Johansson, J., Johnsen, G., Aahlin, E.K., Johannessen, H.-O., Alexandersson von Döbeln, G., Hjortland, G.O., Wang, N., Shang, Y., Borg, D., Quaas, A., Bartella, I., Bruns, C., Schröder, W., Nilsson, M.

“…The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical…”
Get full text